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reatment of Acute Intravascular Thrombi
ith Diagnostic Ultrasound and
ntravenous Microbubbles
eng Xie, MD,* John Lof, MS,* Carr Everbach, PHD,† Anming He, PHD,‡
ichard M. Bennett, PHD,‡ Terry Matsunaga, PHD,§ Jason Johanning, MD,*
homas R. Porter, MD*
maha, Nebraska; Swarthmore, Pennsylvania; Mountain View, California; and Tucson, Arizona
ection Editor: Amir Lerman, MD
he purpose of this studywas to determinewhether highmechanical index (MI) impulses fromdiagnostic
ltrasound (DUS) could dissolve intravascular thrombi using intravenous microbubbles. Using a canine
odel, DUS was applied during a continuous intravenous infusion of microbubbles. Completely throm-
osed grafts were assigned to 2 treatment regimens: low-MI (0.5-MI) ultrasound alone; or intermittent
igh-MI impulses (1.9-MI) guided by low-MI ultrasound (contrast pulse sequencing). A 20-MHz cavitation
etectorwasplacedconfocal to theultrasound transducer tomake intravascular cavitationmeasurements
n 1 dog. Intravascular cavitational activity was detectedwhen anMI of0.5 was applied. In grafts treated
ith intermittent high-MI ultrasound, angiographic success was 71% at 30 min and 79% at 45 min,
omparedwith 20%and 30%at these times in the low-MI ultrasound alone group (p 0.05).We conclude
hat a commercially available DUS transducer can successfully recanalize acute intravascular thrombi
uringa continuousmicrobubble infusion. (JAmColl Cardiol Img2009;2:511–8)©2009by theAmerican
ollege of Cardiology Foundationn
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Vieow-frequency (2 MHz) therapeutic ultra-
ound and intravenous microbubbles are able to
ecanalize acutely thrombosed vessels (1,2).
ne established mechanism in in-vitro studies
s ultrasound-induced cavitation (3), which re-
ults in thrombus dissolution during the micro-
ubbles’ rapid growth and collapse within the
ltrasound field. The utilization of ultrasound
nd microbubbles for this application has sig-
rom the *Department of Internal Medicine/Section of Cardiology
edical Center, Omaha, Nebraska; †Swarthmore College, Swar
ountain View, California; and the §University of Arizona, Tucson
nc., Tucson, Arizona, and Siemens Medical Solutions, Mountainanuscript received October 30, 2008; revised manuscript received Janificant clinical potential in that it can be
ccomplished without requiring systemic anti-
oagulation or fibrinolysis. In vivo studies have
pplied the ultrasound over the affected vessel
ithout knowledge of whether microbubbles
ere present within the thrombus. The fre-
uencies and peak negative pressures required
o induce thrombus dissolution are similar to
hose used with diagnostic transducers, with
e Department of Surgery, University of Nebraska
ore, Pennsylvania; ‡Siemens Medical Solutions,
rizona. Supported in part by ImaRx Therapeutics,
w, California.uary 29, 2009, accepted February 2, 2009.
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512he added advantage that diagnostic devices can
etect whether microbubbles are present within the
hrombus before application of cavitation-inducing
eak negative pressures. Despite these potential
dvantages, insufficient research has been published
o determine whether a diagnostic imaging ultra-
ound transducer could recanalize intravascular
hrombi, and whether a mechanical index (MI) that
nduces cavitation would be required to recanalize
he vessel. The purpose of this study was to deter-
ine whether diagnostic ultrasound, in the pres-
nce of microbubbles, would be capable of recana-
izing deeply located intravascular thrombi without
he need for fibrinolysis or systemic anticoagulation.
ethods
iagnostic ultrasound system measurements. A di-
gnostic ultrasound (DUS) system with a 4C1
ransducer (ACUSON Sequoia 512, Siemens
edical Solutions, Mountain View, California)
as used for all studies. The peak negative
pressures (PNP) generated by this DUS
transducer at different MI settings were
measured using a calibrated 0.5-mm di-
ameter needle hydrophone (Precision
Acoustics Ltd., Dorchester, England).
All measurements were made at 6 cm from
the transducer face through a custom-
designed 6-cm–thick tissue-mimicking
phantom (attenuation 0.49 dB/cm/MHz;
omputerized Imaging Reference Systems, Inc.,
orfolk, Virginia). The image depth was set to 9
m. This transducer has dual focal zones, which
ere placed at 4.5 and 8.0 cm within the field. The
ulse repetition frequency for the transducer was set
o 5 KHz. The transducer was clamped to a stand so
hat it was in a fixed position perpendicular to the
hantom surface. The hydrophone was placed on
he opposite side of the phantom, and aligned with
he ultrasonic axis of the transducer by positioning
he hydrophone at the location of the highest peak
oot mean square pressure amplitude. The MI
etting on the diagnostic transducer was incremen-
ally decreased from 1.9 down to 0.3 in 0.2- to
.3-MI increments. All peak negative pressure
easurements were made in triplicate for each MI
etting. The same tissue-mimicking phantom used
or these peak negative pressure measurements in
he water bath was also used for in vivo studies.
Both high-MI impulses (1.5 MHz, 1.9 MI) and
ow-MI contrast-specific imaging (contrast pulse
cing
d
resequencing [CPS] using a 2.0-MHz center fre- wuency and 0.4 MI) were possible using the same
US transducer. For in vivo studies, high-MI
mpulses at a 7-cycle pulse length were delivered for
to 7 s whenever microbubbles were observed
ransiting through the thrombi within the graft.
ntravenous microbubble infusion. The intravenous
icrobubbles used for continuous infusion in this
tudy were MRX-801 (ImaRx Therapeutics, Inc.,
ucson, Arizona). These are lipid-encapsulated
icrobubbles containing a perfluorocarbon gas.
he mean diameter of the microbubbles was ana-
yzed using a Particle Sizing System Model 770
Particle Sizing Systems, Santa Barbara, Califor-
ia), and were measured to be 1.0  0.1 m, with
1% of the microbubbles being 5.0 m. Micro-
ubble concentration was 1.5 to 3.0 1010/ml. The
icrobubble infusion was prepared, as previously
escribed, by diluting 2 ml of the MRX-801 in 100
l of 0.9% saline, and administering at a rate of 1.8
l/min for 45 min. All infusions were through a
eripheral intravenous line placed in the front leg.
urgical procedures. All animal protocols were ap-
roved by the Institutional Animal Care and Use
ommittee of the University of Nebraska Medical
enter. Three mongrel dogs weighing 25  1 kg
nderwent surgical placement of an arteriovenous
raft in the left groin under inhalation anesthesia
ith 1.2% to 3.0% isoflurane. A 6-mm diameter by
5-cm long dialysis graft (Gore-Tex, W.L. Gore &
ssociates, Flagstaff, Arizona) was implanted be-
ween the femoral artery and femoral vein bilater-
lly, in a loop configuration. The graft was allowed
o mature for 4 weeks. After the maturation period,
he dogs were anesthetized at 1-week intervals, at
hich time thrombotic occlusions of the grafts were
reated. One graft was used for in vivo cavitation
easurements, whereas the other 2 dogs had re-
eated thrombotic occlusions (16 in 1 dog, 8 in the
econd dog) for comparisons of different ultrasound
reatments.
n vivo cavitation measurements. To determine
hether intravascular cavitation was occurring dur-
ng DUS application to a thrombotic occlusion, we
easured inertial cavitational activity in 1 of the
rafts of 1 dog using a 20-MHz single-crystal
ransducer that was positioned confocal to the
iagnostic transducer (Fig. 1). The 20-MHz trans-
ucer passively monitored the presence of cavita-
ional activity during the microbubble infusion,
hereas the MI on the diagnostic transducer was
ncrementally decreased from 1.9 down to 0.3 in
.2- to 0.3-MI increments. Cavitational activityB B R E V I A T I O N S
N D A C R O N YM S
PS contrast pulse sequen
US diagnostic ultrasoun
Imechanical indexas recorded at these MI settings at a time period
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513hen microbubbles were visualized channeling
hrough the thrombosed graft. For these experi-
ents, the diagnostic transducer and overlying
-cm–thick phantom with cavitation monitoring
evice were submerged in a water bath to accom-
odate the cavitation monitor.
tudy protocol. After anesthesia induction, the skin
ite overlying the graft was sterilized, and a 4-F
annula was placed percutaneously in the arterial
roximal limb of the graft. Angiograms using 2-ml
o 3-ml injections of Iohexol 300 (Ominipaque 300,
ycomed Princeton, New Jersey) were performed
o assess patency. Then, a percutaneous double-
uture ligature distal to the tip of the indwelling
annula was used to produce thrombosis of the
raft. Thirty minutes of manual occlusive pressure
as also applied to the graft proximal to the cannula
o assist in thrombus formation. After a median
eriod of 4 h, the suture was removed and throm-
otic occlusion confirmed by angiography.
Based on the results of the in vivo cavitation
xperiments, 2 treatments were compared: (A) in-
ravenous MRX-801 plus low-MI ultrasound
0.4) that was below the experimentally deter-
ined cavitational threshold of the DUS transducer
low-MI DUS); and (B) intravenous MRX-801
lus intermittent high-MI (1.9) ultrasound im-
ulses delivered when low-MI CPS detected mi-
robubbles within the thrombus. This treatment
as termed high-MI/low-MI DUS. All DUS
ransmissions were applied through the 6-cm
issue-mimicking phantom placed on the skin over-
ying the graft, as shown in Figure 1.
In the MRX-801 plus high-MI/low-MI DUS
roup, high-MI ultrasound was applied over the
raft only when low-MI DUS imaging with CPS
onfirmed that microbubbles were present within
he graft. An example of this technique is shown in
igure 2. The duration of high-MI applications was
pproximately 5 s. The duration of low-MI DUS in
etween high-MI applications varied depending on
ow rapid replenishment of contrast was observed
ithin the graft. In the low-MI DUS group, the
I was maintained at 0.4 and continuously
pplied over the graft during the treatment period.
ngiograms of graft patency were repeated at 6, 12,
0, 25, 30, 40, and 45 min of treatment to charac-
erize flow through the graft. Patency of the 4-F
annula for angiograms was maintained by small
uantities of intragraft heparin (cumulative dose:
,000 U over the 45-min treatment period).
Flow scores were used to characterize angio-raphic flow in the graft as previously described. ehe absence of visible flow was graded as 0. Flow
eyond the obstruction that did not completely fill
he graft and was associated with delayed clearance
when compared with the adjacent femoral artery)
as graded as 1. When flow beyond the obstruction
id completely fill the graft but clearance was
elayed, the score was 2. Complete filling of the
raft beyond the obstruction with rapid clearance
as graded as 3. Success was defined as a flow score
f 3.
At the completion of each procedure, any resid-
al thrombosis in the graft was removed with
ntravenous heparin (100 U/kg) and balloon dilata-
ion. The graft was reused for a subsequent ran-
omized treatment at weekly intervals.
tatistical analysis. No corrections were made for
ultiple correlated observations in the same animal.
herefore, the thrombotic occlusion, not the ani-
al, was the unit of analysis to permit statistical
Figure 1. The Set-Up of the 20-MHz Listening Device
(A) Siemens Acuson Sequoia 4C1 probe with a 20-MHz cavitation d
mounted on it. (B) A 4C1 probe insonifying subcutaneous graft thro
6-cm–thick phantom with cavitation monitoring device submerged
bath.etector
ugh
in watervaluation. Eight low-MI/high-MI DUS studies
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514ere performed in the first canine and 6 in the
econd canine, whereas the 10 low-MI DUS studies
ere performed in the second canine. The study
ssignments were randomized in both canines, with
he statistical comparisons in the first canine being
ow-MI/high-MI DUS versus a therapeutic trans-
ucer, and the randomized comparison in the sec-
nd canine being low MI/high DUS versus low-MI
US alone. Continuous data are expressed as mean
SD and were compared using the Student
npaired t test. A chi-square test was used to
ompare differences between 2 groups in the pro-
ortion of grafts that achieved flow grade 3 at 20,
0, and 45 min. A p value 0.05 was considered
emonstration of Low-MI CPS-Guided Applications of High-MI
sing the DUS Transducer
obubbles seemed to maximally penetrate the thrombus (top),
pulses were applied over the graft and this immediately
the microbubbles (middle, blue arrows). After a programmed
transducer switched to low-MI imaging again to examine for
le replenishment (bottom). CPS  contrast pulse sequencing;g
gnostic ultrasound; MI  mechanical index.tatistically significant. The relationship between
he peak negative pressure and MI was analyzed
sing linear regression analysis. All statistics were
alculated using SigmaStat version 3.1 (Systat Soft-
are, Inc., San Jose, California).
esults
eak negative measurements. Figure 3 shows the
NP measurements at the different MI settings.
here was a linear relationship between the PNP
nd MI (r2  0.96, p  0.0001). The PNP
btained for 1.9 MI was 723  12 KPa, and
ecreased with decreasing MI down to 50  7 KPa
t the 0.31-MI setting.
ntravascular cavitation activity within the thrombosed
essel. Cavitational activity within the graft was
etectable only when microbubbles were visualized
ith CPS moving through channels within the
hrombus. Figure 4 depicts the plot of cavitational
ctivity (root mean square voltage of passive 20-
Hz detector) on the y-axis plotted as a function
f the applied MI on the x-axis. The recordings
ere obtained when there was evidence of micro-
ubbles channeling through the thrombus and an-
iographic flow grade 3 within the graft. As can be
een, cavitational activity was recorded all the way
own to 0.5 MI, below which there was an abrupt
ecrease of cavitational activity within the graft.
ecanalization of occluded grafts. Of the 24 acute
Figure 3. Peak Negative Pressure at Different Mechanical
Indexes
The measurements were obtained through the tissue-mimicking
phantom from the diagnostic ultrasound transducer at different
mechanical indexes. There was a linear relationship between the
peak negative pressure and mechanical indexes. CPS  contrast
pulse sequencing.Figure 2. D
Impulses U
When micr
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period, the
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515igh-MI DUS, and 10 with low-MI DUS. Figure
is an example of one of the images obtained
hrough the tissue-mimicking phantom in a dog
eceiving low-MI/high-MI DUS. During low-MI
maging, CPS showed microbubbles filling chan-
els within the thrombus (top panel). When a
igh-MI impulse was applied (middle panel), the
icrobubbles were immediately cleared from the
hannels within the thrombus. After the return to
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Figure 4. Cavitation Emissions at Different Mechanical Indexes
Plot of intravascular cavitational activity within the recanalized
arteriovenous graft during a microbubble infusion as a function
of mechanical index (MI) setting on the 1.5-MHz diagnostic
transducer. Note that cavitation was not observed below 0.5 MI.
Figure 5. An Example of Receiving Low-MI/High-MI DUS Treatm
The increase in channel size (green arrows) within the thrombus as
ment of microbubbles occurred within the channels of the thrombus asow-MI DUS, there was replenishment of micro-
ubbles (bottom panel). In the first 10 min of
reatment, the time intervals between high-MI
ltrasound applications were 21  19 s (ranging up
o as long as 121 s), reflecting slower microbubble
eplenishment because of slower flow through
maller channels within the thrombus early on in
reatment. At subsequent treatment intervals, there
ere progressively shorter time intervals (8  8 s at
0 min into treatment) between high-MI treat-
ents as low-MI CPS detected more rapid micro-
ubble replenishment within the thrombosed graft
s the channels enlarged. These short time replen-
shment intervals were seen only in the dogs in
hom flow grade 3 by angiography (6  5 s
eplenishment interval in grafts with flow grade 3
s. 12  6 s replenishment interval in grafts with
ow grade 3; p  0.001) was achieved.
The angiographic flow scores in the 2 treatment
roups at the different time intervals of treatment
re presented in Table 1. As can be seen, after 30
unction of treatment time. Note the rapidity with which replenish-
Table 1. Recanalization Rates at Different Time Intervals
of Treatment
MRX-801 
Low-MI DUS
MRX-801 
Low-MI/High-MI DUS
20 min 10% 29%
30 min 20% 71%*
45 min 30% 79%*
DUS  diagnostic ultrasound; MI  mechanical index. *p  0.05 compared
with MRX-801  low-MI DUS.ent
a f
a function of treatment time. Abbreviations as in Figure 2.
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516nd 45 min of treatment, the successful recanaliza-
ion rates in the grafts treated with low-MI/
igh-MI DUS were significantly larger than those
reated with low-MI alone. The majority of grafts
reated with intermittent high-MI diagnostic im-
ulses already showed flow grade 3 at 30 min. A
ow score of 3 at 45 min was achieved in 11 of 14
rafts treated with low-MI/high-MI DUS (p 
.05 compared with low-MI DUS). In the canine
n which randomized comparisons between low-
I/high-MI DUS and low-MI alone were made, 5
f the 6 thrombi treated with low-MI/high-MI
ecanalized at 30 min, compared with 2 of 10 in the
ow-MI group (p  0.02). There were no statisti-
ally significant differences between groups in acti-
ated clotting times after the different ultrasound
reatments (110  16 s vs. 122  1 s).
iscussion
achibana and Tachibana (4) first described the im-
act of a nonimaging low-frequency ultrasound trans-
ucer and microbubbles on the effectiveness of fi-
rinolytic agents. These investigators observed, in an
n vitro model, that the combination of urokinase,
ow-frequency ultrasound, and microbubbles resulted
n an increased rate of fibrinolysis when compared
ith urokinase plus ultrasound or urokinase alone. In
itro studies have also indicated that cavitation plays
n important role in ultrasound-induced thrombolysis
3). These cavitation thresholds have been shown to
e lowered in the presence of microbubbles. Our study
ocuments the importance of cavitation for producing
hrombolysis with ultrasound in vivo, in that only
hen we applied the cavitation-producing high-MI
mpulses did we achieve a high degree of success in
ecanalizing the acutely thrombosed grafts.
Ultrasound, used alone or in combination with
icrobubbles, has potentiated the clinical effect of
brinolytic agents in the treatment of stroke in hu-
ans (1,2). The CLOTBUST (Combined Lysis of
hrombus in Brain Ischemia Using Transcranial Ul-
rasound and systemic TPA) trial showed that a
onimaging continuous transcranial Doppler ultra-
ound transducer augments t-PA–induced middle ce-
ebral arterial recanalization. Molina et al. (1) showed
hat administration of microbubbles augmented the
ffectiveness of continuous-wave ultrasound-enhanced
hrombolysis in acute stroke. More recently, Pagola et
l. (2) reported that this same ultrasound technique
nd microbubbles with t-PA leads to early recanaliza-
ion in acute basilar artery occlusion. None of these
linical studies, however, assessed the efficacy of ultra- gound and microbubbles alone. Furthermore, because
hey applied the therapeutic ultrasound in an uninter-
upted fashion, this procedure may have reduced the
ffectiveness of the microbubbles by prohibiting re-
lenishment of microbubbles within the field of inter-
st that would serve as nuclei for the desired cavitation
ffect.
Microbubble-mediated thrombus dissolution
ithout fibrinolytic agents has been shown in ani-
al studies using a variety of echo-contrast agents
n combination with nonimaging therapeutic ultra-
ound devices. These studies were primarily per-
ormed in peripheral vessel thromboses where there
as minimal attenuation of the ultrasound beam. In
he present study, we showed that intravascular
avitational activity occurs within a deeply located
hrombosed vessel when high-MI impulses were
pplied after replenishment of the insonified field
ith microbubbles. We have previously shown that
hrombus dissolution was more effective when a
ondestructive imaging transducer was used to
uide when to apply the high-MI impulses. In the
resent study, we showed that a diagnostic trans-
ucer has the capability of simultaneously being
oth the guiding transducer (at a low MI) and the
herapeutic transducer (brief 1.9-MI impulses). In
he absence of a fibrinolytic agent or systemic
nticoagulation, the angiographic success rate with
ntermittent high-MI DUS and microbubbles was
1% at 30 min and 79% at 45 min, compared with
nly 20% at 30 min and 30% at 45 min in the
ow-MI ultrasound-alone group. Thus, an imaging-
uided approach has the potential to both improve
ecanalization of thrombosed vessels, and also limit
he duration in which high-MI ultrasound needs to
e applied. The low-MI-alone setting played a
inimal role in facilitating sonolysis because the
ngiographic success rates in the grafts receiving
ow MI alone were not different from what we have
bserved in thrombosed grafts treated with un-
uided therapeutic ultrasound and microbubbles in
his setting. Therefore, we propose that it is not just
he induction of cavitation that improves ultra-
ound’s success rate in recanalizing the thrombosed
essel, but an imaging-guided approach that maxi-
izes the presence of microbubbles within the
essel before the application of the cavitation-
nducing impulses.
tudy limitations. One of the limitations in the
tudy was that only 2 dogs were used to test the
ypothesis. The multiple thromboses were created
n each group to overcome the variable that different
rafts pose in influencing outcome. Differences in
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517urgical graft positions and geometry may affect the
bility of any pharmacologic or mechanical therapy
n recanalizing the thrombosed grafts. This is why
e chose a model in which repetitive thromboses
n  24) were created in just 2 grafts of 2 dogs, so
hat any variations in graft geometry or position
ould not affect our comparison of the 2 different
ltrasound settings compared in this study. Al-
hough the age of the thrombus used in this study
ay not be similar to the situation seen in a clinical
raft thrombosis, our goal was more to create an
cute thrombosis in a deeply located vessel, similar
o what may be seen in acute cerebral or coronary
hromboses. In these situations, the thrombus is
ore often of the age used in this study, and we
xpect the findings of our study to be applicable to
hese situations more than a clinical graft
hrombosis.
We did not have a separate group testing what
ffect diagnostic ultrasound alone (without micro-
ubbles) may have in recanalizing the graft throm-
oses. However, we have previously examined what
ffect therapeutic ultrasound alone has in recanaliz-
ng thrombosed arteriovenous grafts like the one in
his study, and the success rate was only 12.5%.
Although the mechanical index setting on a given
ltrasound system serves as a guide for the peak
egative pressure reaching the insonified region,
ow this value is determined varies among different
anufacturers. Thus the mechanical index value
an only serve as an estimation of the peak negative
ressure reaching tissue, and the actual MI setting
hat induces cavitation may vary depending on the
ype of diagnostic system that is being used. For
xample, the high-MI pulses used in this study
machine setting 1.9) produced a peak negative
ressure of 0.723 MPa as measured by the hydro-
hone through the tissue phantom material. The
rue MI, therefore, would be calculated as 1.0 based
n the tissue derating criterion published by the
.S. Food and Drug Administration (5).
Although we did formally evaluate the safety of
ltrasound- and microbubble-mediated thrombus
issolution in this study, we have previously exam-
ned whether there was evidence that this technique
esulted in pulmonary embolization and found no
vidence of this when using a diagnostic
ltrasound-guided technique. Furthermore, we
ave not seen any evidence that ultrasound and
icrobubble–induced recanalization altered right
entricular systolic function or pressures.
We did not determine what additional effectsystemic anticoagulation or lysis therapy may have 2n this technique. It would be assumed that such
dditional therapies would be additive because the
ffects of ultrasound and microbubbles seem to be
ostly mechanical dissolution and not activation of
ytic enzymes.
linical implications. We have shown that a diagnos-
ic ultrasound transducer, operating within U.S.
ood and Drug Administration peak negative pres-
ure limits (4), has the capability to induce intra-
ascular thrombus dissolution when used in com-
ination within intravenous microbubbles. This
maging transducer must also be used to detect
hen microbubbles are present within the throm-
us, and to guide when to apply the high-MI
mpulses. Furthermore, recanalization in this study
as achieved without the need for systemic fibri-
olysis or systemic anticoagulation. Because these
esults were achieved when the DUS was applied
hrough a 6-cm–thick tissue-mimicking phantom,
hey indicate that this method of treatment may be
noninvasive alternative for treating acute throm-
otic occlusions within the coronary or cerebral
irculation. Microbubbles very similar in structure
o the ones used in this study are already commer-
ially available today. Although concerns regarding
he safety of ultrasound contrast agents like the one
sed in this study have recently been raised by the
.S. Food and Drug Administration, subsequent
afety studies have shown that such concerns are not
linically significant. The cumulative doses of
RX-801 used in this animal study were only
lightly above one commercially available vial of
efinity (Lantheus, Inc., North Billerica, Massa-
husetts), and were given repetitively to the same
nimal without evident side effects. In addition, the
iagnostic transducer used for this study is com-
only used for transthoracic imaging in patients.
herefore, we conclude that this technique should
e explored as a method of treating acute intravas-
ular thrombosis in conjunction with anticoagula-
ion or fibrinolytic therapy, or as an alternative
herapy in patients who have contraindications to
nticoagulants or fibrinolytic agents.
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